UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Microbial biofilms in the human gastrointestinal tract

Journal of applied microbiology, 2007-05, Vol.102 (5), p.1187-1196

2007

Volltextzugriff (PDF)

The eradicate-C study-curing people who are actively injecting drugs of hepatitis C: the first step to elimination

Journal of hepatology, 2017, Vol.66 (1), p.S312-S312

2017

Volltextzugriff (PDF)

Injecting heroin – how long until hepatitis C infection obtained?

Journal of hepatology, 2017, Vol.66 (1), p.S274-S274

2017

Volltextzugriff (PDF)

An intelligent liver function tests pathway for the automated assessment of deranged liver enzymes

Journal of hepatology, 2017, Vol.66 (1), p.S237-S237

2017

Volltextzugriff (PDF)

Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort

Journal of hepatology, 2017, Vol.66 (1), p.S22-S23

2017

Volltextzugriff (PDF)

Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR

Journal of hepatology, 2011-11, Vol.55 (5), p.1162-1164

2011

Volltextzugriff (PDF)

911 REAL WORLD HCV SVR RATES OVER 10 YEARS: WHAT IS THE BENCHMARK?

Journal of hepatology, 2013-04, Vol.58, p.S375-S375

2013

Volltextzugriff (PDF)

498 DRY BLOOD SPOT TESTING FOR HEPATITIS C IN PEOPLE WHO INJECTED DRUGS: REACHING THE POPULATIONS OTHER TESTS CANNOT REACH

Journal of hepatology, 2013-04, Vol.58, p.S204-S204

2013

Volltextzugriff (PDF)

P944 THALIDOMIDE THERAPY IN RECURRENT GASTROINTESTINAL BLEEDING DUE TO ANGIODYSPLASIAS

Journal of hepatology, 2014-04, Vol.60 (1), p.S390-S390

2014

Volltextzugriff (PDF)

P801 DO SERUM MARKERS OF CELL INJURY AND DEATH HAVE POTENTIAL TO BECOME MECHANISTIC MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)?

Journal of hepatology, 2014-04, Vol.60 (1), p.S337-S337

2014

Volltextzugriff (PDF)

361 PERFORMANCE OF SIMPLE ALGORITHM TESTS FOR THE DETECTION OF FIBROSIS IN NALFD

Journal of hepatology, 2010, Vol.52, p.S150-S150

2010

Volltextzugriff (PDF)

1119 QUANTIFYING THE EXTENT OF CIRRHOSIS ATTRIBUTABLE TO ALCOHOL AMONG PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C: IMPLICATIONS FOR TREATMENT COST-EFFECTIVENESS STUDIES

Journal of hepatology, 2012-04, Vol.56, p.S441-S441

2012

Volltextzugriff (PDF)

PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care Patients

Value in health, 2011, Vol.14 (7), p.A392-A392

2011

Volltextzugriff (PDF)

422 THE IMPACT OF A MANAGED CARE NETWORK ON ATTENDENCE AT A SPECIALIST HEPATITIS SERVICE AND SUSTAINED VIRAL RESPONSE TO HEPATITIS C TREATMENT

Journal of hepatology, 2009, Vol.50, p.S159-S159

2009

Volltextzugriff (PDF)

867 ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS

Journal of hepatology, 2013-04, Vol.58, p.S356-S356

2013

Volltextzugriff (PDF)

THU-196 - Injecting heroin – how long until hepatitis C infection obtained?

Journal of hepatology, 2017, Vol.66 (1), p.S274-S274

2017

Volltextzugriff (PDF)

THU-278 - The eradicate-C study-curing people who are actively injecting drugs of hepatitis C: the first step to elimination

Journal of hepatology, 2017, Vol.66 (1), p.S312-S312

2017

Volltextzugriff (PDF)

Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial

The Journal of infection, 2022-12, Vol.85 (6), p.676-682

2022

Volltextzugriff (PDF)

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement

Public health (London), 2024-07, Vol.232, p.153-160

2024

Volltextzugriff (PDF)

THU-487 - An intelligent liver function tests pathway for the automated assessment of deranged liver enzymes

Journal of hepatology, 2017, Vol.66 (1), p.S237-S237

2017

Volltextzugriff (PDF)

New cyclic difference sets with Singer parameters

Finite fields and their applications, 2004-07, Vol.10 (3), p.342-389

2004

Volltextzugriff (PDF)

PS-035 - Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort

Journal of hepatology, 2017, Vol.66 (1), p.S22-S23

2017

Volltextzugriff (PDF)

The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

Epidemiology and infection, 2012-06, Vol.140 (6), p.1048-1053

2012

Volltextzugriff (PDF)

Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

Journal of viral hepatitis, 2012-02, Vol.19 (2), p.112-119

2012

Volltextzugriff (PDF)

Near bent functions on a hyperplane

Finite fields and their applications, 2008-07, Vol.14 (3), p.715-720

2008

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(151)

Erscheinungsjahr

n.n

Thema

Science & Technology
(62)
Physical Sciences
(35)
Physics
(32)
Life Sciences & Biomedicine
(29)
Algebra
(26)
Humans
(16)
Female
(13)
Gastroenterology And Hepatology
(13)
Physics, Multidisciplinary
(11)
Animals
(10)
High Energy Physics - Experiment
(10)
Physics Of Elementary Particles And Fields
(10)
Biological And Medical Sciences
(9)
Male
(9)
Technology
(9)
Elementary Particles
(8)
Physics, Condensed Matter
(8)
Decay
(7)
Interactions
(7)
Materials Science
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Microbial biofilms in the human gastrointestinal tract

The eradicate-C study-curing people who are actively injecting drugs of hepatitis C: the first step to elimination

Injecting heroin – how long until hepatitis C infection obtained?

An intelligent liver function tests pathway for the automated assessment of deranged liver enzymes

Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort

Pre-treatment prediction of response to pegylated-interferon plus ribavarin for chronic hepatitis C using RVR

911 REAL WORLD HCV SVR RATES OVER 10 YEARS: WHAT IS THE BENCHMARK?

498 DRY BLOOD SPOT TESTING FOR HEPATITIS C IN PEOPLE WHO INJECTED DRUGS: REACHING THE POPULATIONS OTHER TESTS CANNOT REACH

P944 THALIDOMIDE THERAPY IN RECURRENT GASTROINTESTINAL BLEEDING DUE TO ANGIODYSPLASIAS

P801 DO SERUM MARKERS OF CELL INJURY AND DEATH HAVE POTENTIAL TO BECOME MECHANISTIC MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)?

361 PERFORMANCE OF SIMPLE ALGORITHM TESTS FOR THE DETECTION OF FIBROSIS IN NALFD

1119 QUANTIFYING THE EXTENT OF CIRRHOSIS ATTRIBUTABLE TO ALCOHOL AMONG PATIENTS CHRONICALLY INFECTED WITH HEPATITIS C: IMPLICATIONS FOR TREATMENT COST-EFFECTIVENESS STUDIES

PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care Patients

422 THE IMPACT OF A MANAGED CARE NETWORK ON ATTENDENCE AT A SPECIALIST HEPATITIS SERVICE AND SUSTAINED VIRAL RESPONSE TO HEPATITIS C TREATMENT

867 ARE CURRENT TREATMENT RATES SUFFICIENT TO REDUCE HCV PREVALENCE AMONG PEOPLE WHO INJECT DRUGS? MODEL PROJECTIONS IN SEVEN UK SETTINGS

THU-196 - Injecting heroin – how long until hepatitis C infection obtained?

THU-278 - The eradicate-C study-curing people who are actively injecting drugs of hepatitis C: the first step to elimination

Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial

The implementation of a hepatitis C testing service in community pharmacies: I-COPTIC consensus statement

THU-487 - An intelligent liver function tests pathway for the automated assessment of deranged liver enzymes

New cyclic difference sets with Singer parameters

PS-035 - Among Cirrhotic Patients with a Hepatitis C Sustained Viral Response, the Risk of De-novo Hepatocellular Carcinoma Relates to Baseline Factors and Not the Use of Direct Acting Antivirals: Results from a Nationwide Cohort

The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population

Intravenous drug use: not a barrier to achieving a sustained virological response in HCV infection

Near bent functions on a hyperplane

Suchergebnisse filtern